These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17576788)

  • 41. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load.
    Dennert R; Velthuis S; Schalla S; Eurlings L; van Suylen RJ; van Paassen P; Tervaert JW; Wolffs P; Goossens VJ; Bruggeman C; Waltenberger J; Crijns HJ; Heymans S
    Antivir Ther; 2010; 15(2):193-201. PubMed ID: 20386074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous IgG: supertherapy for myocarditis and acute dilated cardiomyopathy.
    Kishimoto C; Takada H; Hiraoka Y
    Circulation; 1999 Feb; 99(7):975. PubMed ID: 10027823
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of neonatal lupus: case report and review of the literature.
    Rider LG; Buyon JP; Rutledge J; Sherry DD
    J Rheumatol; 1993 Jul; 20(7):1208-11. PubMed ID: 8371220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of refractory cutaneous lupus vasculitis with i.v. immunoglobulin.
    Takamuki R; Okiyama N; Inoue S; Endo R; Kondo Y; Chino Y; Sumida T; Fujimoto M
    J Dermatol; 2019 Jul; 46(7):e253-e255. PubMed ID: 30714643
    [No Abstract]   [Full Text] [Related]  

  • 45. [Acute renal failure after intravenous use of immunoglobulin to treat myocarditis].
    Pordeus V; Tostes A; Mesquita CT; Mady C; Mesquita ET
    Arq Bras Cardiol; 2005 Feb; 84(2):167-9. PubMed ID: 15761642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunoglobulin levels in systemic lupus erythematosus: A narrative review.
    Almaghlouth I; Johnson SR; Pullenayegum E; Gladman D; Urowitz M
    Lupus; 2021 May; 30(6):867-875. PubMed ID: 33779380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases].
    Laghi Pansini F; Capecchi PL; Bellisai F; Lazzerini PE; Galeazzi M
    Reumatismo; 2003; 55(4):209-19. PubMed ID: 14872219
    [No Abstract]   [Full Text] [Related]  

  • 48. Successful treatment of leucocytoclastic vasculitis and pancytopenia secondary to systemic lupus erythematosus with intravenous immunoglobulin.
    Perez C; Guarch R; Rodrigo M; Gallego M; Ormazabal O
    Br J Dermatol; 2002 Jul; 147(1):180-2. PubMed ID: 12100207
    [No Abstract]   [Full Text] [Related]  

  • 49. Cutaneous vasculitis in lupus treated with IV immunoglobulin.
    Stumpf MAM; Quintino CR; Rodrigues MAVM; de Campos FPF; Maruta CW
    Clin Rheumatol; 2021 Jul; 40(7):3023-3024. PubMed ID: 33620585
    [No Abstract]   [Full Text] [Related]  

  • 50. Intravenous Immunoglobulin for Bilateral Phrenic Nerve Palsy Due to Neonatal Lupus Erythematosus.
    Paswal CM; Kaur N; Baranwal AK; Jindal A; Saini AG; Bhatia A
    Indian J Pediatr; 2022 Jul; 89(7):734. PubMed ID: 35579843
    [No Abstract]   [Full Text] [Related]  

  • 51. Rapid recovery from acute, potentially lethal myocarditis.
    Eleftheriou AE; Stamatelopoulos SF
    J Int Med Res; 2009; 37(5):1522-5. PubMed ID: 19930860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-dose intravenous gamma-globulin in systemic lupus erythematosus.
    Oliet A; Hernández E; Gallar P; Vigil A
    Nephron; 1992; 62(4):465. PubMed ID: 1300444
    [No Abstract]   [Full Text] [Related]  

  • 53. High-dose immunoglobulin G therapy for fulminant myocarditis.
    Takeda Y; Yasuda S; Miyazaki S; Daikoku S; Nakatani S; Nonogi H
    Jpn Circ J; 1998 Nov; 62(11):871-2. PubMed ID: 9856608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous immunoglobulin infusion causing pseudohyponatremia.
    Ng SK
    Lupus; 1999; 8(6):488-90. PubMed ID: 10483022
    [No Abstract]   [Full Text] [Related]  

  • 55. Intravenous immunoglobulin in urticaria.
    Jandus P; Hausmann O; Pichler WJ; Helbling A
    J Investig Allergol Clin Immunol; 2013; 23(1):71-3. PubMed ID: 23653985
    [No Abstract]   [Full Text] [Related]  

  • 56. Positive pregnancy outcome in an anti-SSA positive female with SLE and factor V Leiden following bimonthly IVIG administration.
    Dahl M; Deleuran B
    Scand J Rheumatol; 2022 Sep; 51(5):425-427. PubMed ID: 35670480
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of scleromyxedema with intravenous immunoglobulin.
    Roque Diamantino Fde E; Lopes João AM; Clemente Fidalgo AI; Taveira Lobo Mde L
    Eur J Dermatol; 2010; 20(6):861-2. PubMed ID: 20956104
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute renal failure and myocarditis associated with intravenous immunoglobulin therapy.
    Akhtar I; Bastani B
    Ann Intern Med; 2003 Aug; 139(4):W65. PubMed ID: 12966002
    [No Abstract]   [Full Text] [Related]  

  • 59. Intravenous Immunoglobulin and Its Clinical Applications.
    De Ranieri D
    Pediatr Ann; 2017 Jan; 46(1):e6-e7. PubMed ID: 28079911
    [No Abstract]   [Full Text] [Related]  

  • 60. Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review.
    Meridor K; Shoenfeld Y; Tayer-Shifman O; Levy Y
    Medicine (Baltimore); 2021 May; 100(18):e25591. PubMed ID: 33950936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.